Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Menitorix Co-administered with Infanrix Penta in Infants
NCT00352963Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hib-MenC-TT in Haemophilus influenzae type b infection (Hib), Meningococcal disease serogroup C (MenC), sponsored by GSK. Started Sep 2003; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Haemophilus influenzae type b infection (Hib)Meningococcal disease serogroup C (MenC)
Beyond the preview
Go deeper on NCT00352963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352963.